Evaluation of reserpine and methyl phenidylacetate used separately and in combination in chronic psychotic patients.
D004565:Electroconvulsive Therapy; D001523:Mental Disorders; D008774:Methylphenidate / Q000627:therapeutic use*; D011612:Psychosurgery; D011618:Psychotic Disorders / Q000628:therapy*; D012110:Reserpine / Q000627:therapeutic use*
D008774:Methylphenidate; D012110:Reserpine
METHYLPHENIDYLACETATE/therapeutic use; PSYCHOSES/therapy; RESERPINE/therapeutic use